Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating ...

Recursion reported second-quarter revenue of $19.22 million, beating analyst estimates of $16.23 million, according to ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Tuesday reported a loss of $171.9 million in its second quarter. On a per-share basis, the Salt Lake City-based ...

SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...

Hillis’ provocative title is a reference to the way that certain simplifying assumptions that underpin the formal models on ...

B stacks up against GPT-4o in practical tests. From coding to logic and creativity, here’s the side-by-side you’ve been ...

Adaptivity need reflects environmental stability. If your APIs and interfaces stay constant for months, score 1. If you’re scraping websites that redesign weekly or dealing with unique inputs each ...

Discover how self-improving AI systems are redefining innovation, reshaping industries, and challenging our understanding of creativity.

AI models may adapt their behaviour based on feedback or changing environments, forming strategies that were not pre-defined. In competitive settings like games, models might bluff, deceive, or ...